Can aspirin or aleve stop cancer before it starts?
NCT ID NCT05411718
Summary
This study is testing whether two common over-the-counter pain relievers, aspirin or naproxen (like Aleve), can help prevent cancer in people with Lynch syndrome—a genetic condition that greatly increases cancer risk. Researchers will give 40 participants one of these drugs for a year to see if they boost immune cells in the colon and reduce polyp growth. The goal is to see if these safe, widely available medications could be a simple prevention strategy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.